Education
About Us
Working with TipRanks
Follow Us
Elanco Animal Health (ELAN)
NYSE:ELAN
ELAN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.02 - $18.80
Previous CloseN/A
Volume2.53M
Average Volume (3M)5.24M
Market Cap
$4.70B
Enterprise Value$9.96B
Total Cash (Recent Filing)-$258.80M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)13.9
Beta1.48
Next Earnings
May 07, 2025EPS Estimate
0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.68
Shares Outstanding496,458,370
10 Day Avg. Volume5,484,177
30 Day Avg. Volume5,238,237
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.17
Price to Cash Flow (P/CF)7.40
P/FCF Ratio10.50
Enterprise Value/Market Cap2.12
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.22
Enterprise Value/Ebitda20.05
Forecast
1Y Price Target
$13.83Price Target Upside46.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
---
Elanco Animal Health News
---
Bulls Say, Bears Say
Bulls Say
Debt ReductionCompany paid down 25% of its debt in 2024 to reach 4.3x leverage versus 5.6x in 2023.
Product Launch SuccessZenrelia and Credelio Quattro continue to track ahead of expectations and Bovaer is gaining solid traction in livestock with positive early feedback and growth.
Revenue GrowthStrong revenue growth for Pet Health is anticipated to offset some challenges in Farm Animal sales.
Bears Say
Earnings ForecastThe updated 2025 earnings guidance is below market expectations.
Foreign Exchange ImpactFX remains a major headwind for ELAN, with an expected drag of $45mn on Adj EBITDA, $110mn on revenue, and 7c on Adj EPS.
Manufacturing And Marketing CostsInvestment in manufacturing and sales and marketing is necessary for future growth but creates downward pressure on the stock.
---
Ownership Overview
0.95% Insiders
47.49% Mutual Funds
1.16% Other Institutional Investors
35.77% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ELAN FAQ
What was Elanco Animal Health’s price range in the past 12 months?
Elanco Animal Health lowest stock price was $8.02 and its highest was $18.80 in the past 12 months.
What is Elanco Animal Health’s market cap?
Elanco Animal Health’s market cap is $4.70B.
When is Elanco Animal Health’s upcoming earnings report date?
Elanco Animal Health’s upcoming earnings report date is May 07, 2025 which is in 10 days.
How were Elanco Animal Health’s earnings last quarter?
Elanco Animal Health released its earnings results on Feb 25, 2025. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.149 by -$0.009.
Is Elanco Animal Health overvalued?
According to Wall Street analysts Elanco Animal Health’s price is currently Undervalued.
Does Elanco Animal Health pay dividends?
Elanco Animal Health does not currently pay dividends.
What is Elanco Animal Health’s EPS estimate?
Elanco Animal Health’s EPS estimate is 0.31.
How many shares outstanding does Elanco Animal Health have?
Elanco Animal Health has 496,458,370 shares outstanding.
What happened to Elanco Animal Health’s price movement after its last earnings report?
Elanco Animal Health reported an EPS of $0.14 in its last earnings report, missing expectations of $0.149. Following the earnings report the stock price went down -3.69%.
Which hedge fund is a major shareholder of Elanco Animal Health?
Currently, no hedge funds are holding shares in ELAN
---
Elanco Animal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.83 (46.19% Upside)
$13.83 (46.19% Upside)
Blogger Sentiment
Neutral
ELAN Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 3.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $483.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 2.2%
Last 30 Days ▼ 2.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.45%
12-Months-Change
Fundamentals
Return on Equity
5.49%
Trailing 12-Months
Asset Growth
-12.17%
Trailing 12-Months
Company Description
Elanco Animal Health
Elanco Animal Health Incorporated (ELAN) is a global leader in animal health, dedicated to innovating and delivering products and services to improve the health of animals. The company operates in two primary segments: Companion Animal and Farm Animal. Elanco's core products include pharmaceuticals, vaccines, and parasiticides aimed at enhancing the health and well-being of pets and livestock, ultimately contributing to food safety and animal welfare globally.
---
ELAN Company Deck
---
ELAN Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and successful debt reduction, driven by innovation and strategic execution in both Pet Health and Farm Animal segments. However, the call also acknowledged challenges due to foreign exchange headwinds and slower than expected adoption of certain products. Overall, the sentiment was cautiously optimistic, with a focus on continued growth and innovation.Read More>---
ELAN Stock 12 Month Forecast
Average Price Target
$13.83
▲(46.19% Upside)
Technical Analysis
Best Analysts Covering ELAN
1 Year
1 Year Success Rate
6/11 ratings generated profit
1 Year Average Return
+8.33%
reiterated a sell rating 12 months ago
Copying Nathan Rich's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +8.33% per trade.
---